- Home
- ORKA vs AHCO Comparison
ORKA vs AHCO Comparison
Compare ORKA & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- AHCO
- Stock Information
- Founded
- ORKA 2004
- AHCO 2012
- Country
- ORKA United States
- AHCO United States
- Employees
- ORKA N/A
- AHCO N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AHCO Medical/Nursing Services
- Sector
- ORKA Health Care
- AHCO Health Care
- Exchange
- ORKA Nasdaq
- AHCO Nasdaq
- Market Cap
- ORKA 1.2B
- AHCO 1.2B
- IPO Year
- ORKA N/A
- AHCO N/A
- Fundamental
- Price
- ORKA $27.70
- AHCO $9.41
- Analyst Decision
- ORKA Strong Buy
- AHCO Strong Buy
- Analyst Count
- ORKA 8
- AHCO 5
- Target Price
- ORKA $44.38
- AHCO $13.40
- AVG Volume (30 Days)
- ORKA 472.9K
- AHCO 768.3K
- Earning Date
- ORKA 11-12-2025
- AHCO 11-04-2025
- Dividend Yield
- ORKA N/A
- AHCO N/A
- EPS Growth
- ORKA N/A
- AHCO N/A
- EPS
- ORKA N/A
- AHCO 0.54
- Revenue
- ORKA N/A
- AHCO $3,240,757,000.00
- Revenue This Year
- ORKA N/A
- AHCO $0.89
- Revenue Next Year
- ORKA N/A
- AHCO $6.84
- P/E Ratio
- ORKA N/A
- AHCO $17.51
- Revenue Growth
- ORKA N/A
- AHCO N/A
- 52 Week Low
- ORKA $5.49
- AHCO $7.11
- 52 Week High
- ORKA $30.51
- AHCO $11.63
- Technical
- Relative Strength Index (RSI)
- ORKA 73.15
- AHCO 55.83
- Support Level
- ORKA $25.11
- AHCO $9.20
- Resistance Level
- ORKA $27.75
- AHCO $9.71
- Average True Range (ATR)
- ORKA 2.14
- AHCO 0.28
- MACD
- ORKA -0.02
- AHCO 0.05
- Stochastic Oscillator
- ORKA 83.24
- AHCO 72.81
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About AHCO AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.